Advanced Antipathogenic Face Mask Innovation

The original antipathogenic face mask patent, while effective, has inherent limitations. For instance, the silicon nitride powder embedded in the fibrous material layer may not provide optimal inactivation of pathogens. Furthermore, the face mask's breathability, comfort, and risk of cross-contamination were not fully addressed. The present invention solves these problems by introducing innovative solutions that enhance the antipathogenic properties, breathability, comfort, and safety of face masks.

The present invention's novelty lies in the innovative integration of silicon nitride compositions and layers that provide enhanced inactivation of pathogens, improved breathability, comfort, and reduced risk of cross-contamination. The inventive step resides in the combination of these features, which overcome the limitations of the original patent and provide a significant advancement in the field of antipathogenic face masks.

Alternative embodiments of the invention may include varying the concentration of silicon nitride, using different types of fibrous materials, or incorporating additional features such as antimicrobial coatings or UV light disinfection. Variations of the invention may also include adapting the silicon nitride composition for use in other personal protective equipment, such as gloves or gowns.

The present invention has significant commercial potential in the personal protective equipment (PPE) industry, particularly in the context of the COVID-19 pandemic. The enhanced antipathogenic face masks and systems can be marketed to healthcare professionals, essential workers, and the general public, providing a safer and more effective solution for preventing the spread of pathogens.